Showing posts with label research. Show all posts
Showing posts with label research. Show all posts

Believe what your customers do...not what they say!

To keep things simple, this blog has moved to the IMTJ web site. You can find the Health Tourism Blog here in future. Here's an extract of the latest blog post entitled: "Believe what your customers do...not what they say!"

A recent article in Harvard Business Review, “Four Simple Low Resolution Innovation Tests” highlights the problem faced by anyone who is considering investment in the medical tourism business. How can you know whether people will actually buy your service i.e. whether patients will actually travel abroad to use your services?

Much of the “research” conducted in the medical tourism sector is about what people say they will do.... not about what they actually do. For example, the 2009 Gallup Survey in the USA is frequently used to support the “booming medical tourism market” hypothesis.

The report on this Gallup poll was headed “Americans Consider Crossing Borders for Medical Care”. It found that “up to 29% of Americans would consider traveling abroad for medical procedures”.

Now the key words here are “will consider”. It does not say “will travel” or “have travelled”. And there lies the problem.......

.........Read the full article at IMTJ: Go to "Believe what your customers do...not what they say!"


McKinsey and the medical tourism numbers game...

According to a new report on medical tourism from McKinsey (login required):
  • "Between 60,000 and 85,000 people annually travel abroad for inpatient hospital care, a number.....far lower than commonly assumed".

According to the Wall Street Journal:

  • ... the McKinsey report "contrasts sharply" with common assumptions and with figures often used by those who market medical tourism. "There's been an enormous amount of hype" regarding people traveling abroad to receive necessary procedures at a lower cost, Mango (from McKinsey) said.

So what are we to make of this "authoritative" report.....?

One industry insider who has compiled a comprehensive review of medical tourism suggests:

  • "The McKinsey figures are nonsensical......looking just at figures from Asia for travellers from Asia and the Gulf, they are way way out."

One problem with the McKinsey data is that it relies heavily on government statistics, and few governments record medical travel. Even where figures are collected then they do not include home nationals who work overseas going back for treatment, or US and other residents returning to a country of origin for treatment.

It's also a strange method of counting medical tourists, if you decide to leave out:

  • people travelling across borders for treatment, which would include UK to France or Belgium, Canada to the US, the US to Mexico, Mexico to the US , China to Taiwan or Hong Kong, central Africa to South Africa , Ireland to the UK, etc etc.
  • people travelling back to their homeland for treatment.
  • people travelling to the homeland of their parents/grandparents
  • expatriates working overseas
  • people who decide to mix travel and treatment eg UK travellers to Spain, South Africa
  • people who mix business travel and treatment
  • people who live in two countries eg UK and Spain
  • And..all outpatients

Other oddities...

If they reckon the number of medical tourists are 60,000 to 85,000 worldwide, how does this stack up against other reported data:

  • 70,000 - 100,000 UK medical tourists (from our own Treatment Abroad medical tourism research and the UK International Passenger Survey data)
  • Last year, 92,000 patients from the UAE visited the Philippines.
  • One dental clinic alone in Budapest that is treating over 4,000 patients from abroad each year.
  • 10,000 visitors to Korea last year for medical treatment, according to the Korean Tourism Organisation.
  • Singapore Tourism Board says 555,000 tourists received medical treatment in 2006.

And overall... it is a little strange to say that someone travelling overseas for a hip operation is a medical tourist, but someone travelling for a dental extraction or cosmetic surgery is not.

Whatever the real numbers are, McKinsey did conclude:

  • "Medical travel is a highly relevant market ........ The acceleration of unsustainable health care costs in many developed economies, the advent of advanced technologies in just a few locations, and the increasing concentration of wealth in developing economies are only a few of the factors fueling it. Over the next couple of decades, these trends may largely dispel the idea that health care is a purely local service"

So... good news for the medical travel industry!

Do concerns about MRSA and hospital infection drive patients abroad?

Medical tourists who travel abroad for treatment, don't just do it to save money. In our soon to be published "Medical Tourism Survey", 56% of the respondents who went for elective surgery abroad said that worries about the risk of MRSA/hospital infection in NHS hospitals were a "Very Important" or "Quite Important" factor.

According to the Health Protection Agency's latest data, there was an 18 per cent drop in cases of MRSA in England from July to September compared to the previous quarter (April to June). This is a drop of about 230 cases per quarter. however, there were still 1,072 cases reported in England during July to September 2007 .

The latest C. difficile figures show that there were 10,734 cases in patients aged 65 years and over in England, reported in the third quarter of 2007. This is a 21% decrease on the previous quarter. In patients between 2 and 64 years of age, 2,496 C. difficile cases were reported in the third quarter of 2007.

So.... there is some indication that the NHS is having some success in improving its poor reputation for hospital infection. But there's an awfully long way to go. The UK is way behind countries such as Norway, Sweden, the Netherlands, Czech Republic and Spain in controlling MRSA and hospital infection rates. (See MRSA statistics in UK and Europe).

Until the NHS can reduce hospital infection rates to a minimal level, patient concerns will continue to be a factor in why people choose treatment in private hospitals in the UK or treatment abroad.